Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.864
+0.004 (0.22%)
Aug 7, 2026, 12:41 PM EDT - Market open
Annovis Bio Employees
Annovis Bio had 7 employees as of December 31, 2025. The number of employees decreased by 8 or -53.33% compared to the previous year.
Employees
7
Change (1Y)
-8
Growth (1Y)
-53.33%
Revenue / Employee
n/a
Profits / Employee
-$5,846,216
Market Cap
79.30M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 7 | -8 | -53.33% | 7 | 0 |
| Dec 31, 2024 | 15 | -1 | -6.25% | 8 | 7 |
| Dec 31, 2023 | 16 | 11 | 220.00% | 6 | 10 |
| Dec 31, 2022 | 5 | 2 | 66.67% | 5 | 0 |
| Dec 31, 2021 | 3 | 1 | 50.00% | 3 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| PolyPid | 75 |
| Elicio Therapeutics | 33 |
| Gain Therapeutics | 21 |
| LeonaBio | 19 |
| Atara Biotherapeutics | 13 |
| MAIA Biotechnology | 13 |
| Eloxx Pharmaceuticals | 10 |
ANVS News
- 4 days ago - Annovis Bio Slides: Investor presentation - Filings
- 4 weeks ago - Annovis Bio initiated with a Buy at Roth Capital - TheFly
- 4 weeks ago - Annovis Bio announces full enrollment for buntanetap trial - TheFly
- 4 weeks ago - Annovis Reaches Full Enrollment in Pivotal Phase 3 Trial of Buntanetap for Early Alzheimer's Disease - GlobeNewsWire
- 5 weeks ago - Annovis Bio promotes Cheng Fang to chief scientific officer - TheFly
- 5 weeks ago - Annovis Appoints Cheng Fang, Ph.D., as Chief Scientific Officer - GlobeNewsWire
- 2 months ago - Annovis Bio regains NYSE listing compliance - TheFly
- 2 months ago - Annovis Bio Regains NYSE Listing Compliance - GlobeNewsWire